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Abstract
This commentary intends to instigate discussions about upcoming epidemiologic research, and its interpretation,
into putative links between shift work, involving circadian disruption or chronodisruption [CD], and the develop-
ment of internal cancers.
In 2007, the International Agency for Research on Cancer (IARC) convened an expert group to examine the carci-
nogenicity of shift work, inter alia characterized by light exposures at unusual times. After a critical review of pub-
lished data, the following was stated: “There is sufficient evidence in experimental animals for the carcinogenicity of
light during the daily dark period (biological night)”. However, in view of limited epidemiological evidence, it was
overall concluded: “Shiftwork that involves circadian disruption is probably carcinogenic to humans (Group 2A)”.
Remarkably, the scenario around shift work, CD and internal cancers provides a unique case for “white-box” epidemiol-
ogy: Research at many levels - from sub-cellular biochemistry, to whole cells, to organs, to organisms, including animals
and humans - has suggested a series of quite precise and partly related causal mechanisms. This is in stark contrast to
instances of “black box” or “stabs in the dark” epidemiology where causal mechanisms are neither known nor hypothe-
sized or only poorly defined. The overriding theme that an adequate chronobiological organization of physiology can
be critical for the protection against cancer builds the cornerstone of biological plausibility in this case.
We can now benefit from biological plausibility in two ways: First, epidemiology should use biologically plausible
insights into putative chains of causation between shift work and cancer to design future investigations. Second,
when significant new data were to become available in coming years, IARC will re-evaluate cancer hazards associated
with shift work. Biological plausibility may then be a key viewpoint to consider and, ultimately, to decide whether (or
not) to pass from statistical associations, possibly detected in observational studies by then, to a verdict of causation.
In the meantime, biological plausibility should not be invoked to facilitate publication of epidemiological research
of inappropriate quality. Specific recommendations as to how to design, report and interpret epidemiological
research into biologically plausible links between shift work and cancer are provided.
Epidemiology is certainly a poor tool
for learning about the mechanism
by which a disease is produced,
but it has the tremendous advantage
that it focuses on the diseases and the deaths
that actually occur,
and experience has shown that it continues to be second to none as
a means of discovering links
in the chain of causation
that are capable of being broken.
-Sir Richard Doll [1]
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An editorial [2] accompanying a 2010 special theme
issue of the Scandinavian Journal of Work, Environment
&H e a l t hpointed out that shift work has been a public
health concern since the 1800s. Understandably, a large
number of studies have addressed numerous health con-
cerns associated with shift work. However, only recently
has a new candidate effect been added to the list,
namely cancer.
With the following, I would like to instigate and fuel
discussion of challenges which inevitable shift work, and
research into shift work and cancer, will pose in the
future. First, I provide background to understand how
the International Agency for Research on Cancer
[IARC] has provided the incentive for epidemiological
studies which investigate “probable” cancer hazards
associated with shift work [3]. Second, I explain why
researching the ‘shift work-cancer-conundrum’ provides
au n i q u ec a s ef o r“white-box” epidemiology. Third, I
s u g g e s th o wt od e s i g n ,r e p o r ta n di n t e r p r e to b s e r v a -
tional investigations into biologically plausible links
between shift work and cancer.
Discussion
A key reason why coming years will bring a cascade of
epidemiologic studies into putative links between shift
work and cancer has been provided in 2007: At that time,
IARC convened an expert group to examine the carcino-
genicity of shift work, inter alia characterized by light
exposures at unusual times. After a critical review of pub-
lished data relevant to an assessment of carcinogenicity,
the following was stated: (i) “There is sufficient evidence
in experimental animals for the carcinogenicity of light
during the daily dark period (biological night)”.
(ii) “There is limited evidence in humans for the carcino-
genicity of shiftwork that involves night work”.O nt h e
basis of (i) and (ii), the 22 working group participants
concluded, (iii) “Shiftwork that involves circadian disrup-
tion is probably carcinogenic to humans (Group 2A)”.
Importantly, the panel judged the evidence from stu-
dies of cancer in experimental animals, and from
mechanistic and other relevant data, to be so strong
that even a Group 1 classification (carcinogenic to
humans) of shift work was contemplated. At the time,
though, the epidemiological evidence in humans for the
alleged links was considered limited, thus the Group 2A
classification (probably carcinogenic to humans)o nb a l -
ance of all scientific literature that was openly available,
i.e., published or accepted for publication, in 2007.
One future scenario to place shift work, involving cir-
cadian disruption or chronodisruption, in the Group 1
category would be when evidence of carcinogenicity
in humans were no longer less than sufficient as
it was considered to be in 2007 [3]. With the given
background, it seems not unrealistic to anticipate the
following: Provided that we are going to see a number
of ‘positive association’ studies in coming years, the
“probable” link between shift work, circadian disruption
and cancers in humans can likely be judged as being
causal. To clarify, ‘positive association’ studies are meant
to denote studies in which we were to observe that shift
work, or some facet of this organizational feature of
work, is positively associated with cancer. In other
words, ‘positive association’ studies would be investiga-
tions showing a higher cancer rate in cohorts who are
exposed than in cohorts who are not exposed to shift
work or to detect a higher likelihood of exposure to
shift work in cancer cases than in controls without the
disease.
In 1965, Bradford Hill [4] suggested a set of “nine dif-
ferent viewpoints from all of which we should study
association before we cry causation”. In the case around
shift work and cancer it seems to me that the state-of-
affairs may be different, i.e., somewhat shortened and to
be possibly settled on one condition: Indeed, one likely
line of action might be a Group 1 classification of shift
work with circadian disruption under the surmised sce-
nario of ‘positive association’ studies in the next years.
Put differently: If there were epidemiological reports of
positive statistical associations in the near(er) future, the
question might not be “association or causation” [4].
Rather, we may be facing the following equation: ‘Asso-
ciation = causation’. In simple, albeit provocative, words,
‘bring us the associations and we will call it causation’.
Shift work, cancer and epidemiology
The background facts are bleak: On the one hand, shift
work is inevitable today as there is work to do for peo-
ple over 24 hours, everyday. To deliver such work at
unusual times, 15-20 percent of male and female work-
e r si nE u r o p ea n dt h eU S Aa r ee n g a g e di nr e g i m e n s
involving night work, i.e., in time-windows that contain
the so-called biological night [3]. On the other hand,
possibly associated breast and prostate cancers are two
of the most common cancers in the world. Given the
fact that many shift workers may be exposed to circa-
dian disruption or chronodisruption, even small - let
alone substantial - risk elevations could translate into
numerous attributable cases. Therefore, resolution of
the question whether we are looking at a chain of causa-
tion between shift work, CD and the development of
cancer is very important for public health. That epide-
miologists will have a key role in the upcoming quest
for associations seems reasonable to expect. In line with
Doll’s 1996 statement quoted earlier, observational stu-
dies will now provide the means to look with care for
the causes of cancers which actually occur in female
and male shift workers.
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Conceptually, the ‘shift work-cancer-conundrum’ con-
fronts us with a unique situation of “white-box” epide-
miology [5]: A series of - quite precise and partly
related - causal mechanisms has been suggested. Empiri-
cally, several biological mechanisms [[3]: “Exposure to
light at night disturbs the circadian system with altera-
tions of sleep-activity patterns, suppression of melatonin
production, and deregulation of circadian genes involved
in cancer-related pathways"] have been established in
animal experiments and by mechanistic and other
data. In addition, a generalized “chronodisruption-
cancer-theory” [6] was proposed. Taken together,
advanced biological knowledge, namely experimental
insights into biologically plausible disease mechanisms
involving circadian disruption or chronodisruption, can
provide the basis for coherent “white-box” epidemiology.
This is in stark contrast to instances of “black box” or
“stabs in the dark” [7] epidemiology: There, at least
when the studies are designed and analyzed, causal
mechanisms are neither known nor hypothesized or
only poorly defined. In the case of shift work and can-
cer, biological insights and plausibility can now be used
at two critical stages of the scientific and public health
endeavour: To appropriately collect, and to ultimately
weigh, observational evidence in the course of the causal
inference process. In short, abundant biomedical
insights should be used to design and refine observa-
tional studies soon and can contribute to weighing
observed evidence for and against causality later.
So, how can “white-box” epidemiology contribute to
collecting observational data? To this end, “Building on
laboratory findings may allow epidemiologists to exam-
ine more specific forms of exposure, disease, and their
relation, which leads to more rigorous testing. When
the biological context can be used to improve measure-
ment of dose or specify modifiers of the association, the
resulting epidemiologic study is enhanced” [7]. By incor-
porating insights into biology in their design, epidemio-
logical studies may capture associations as expressions
of biological cause-effect-relationships that are at work
(or not) more precisely. In principle, “white-box” epide-
miological studies can produce higher, lower or zero
risks when compared with results observed in studies
which were designed without detailed mechanistic
knowledge.
And how can “white-box” epidemiology contribute to
ultimately weighing the overall evidence for or against
causality? A lucid way to illustrate the process of causal
inference may be borrowed, albeit with variation, from
Raymond Neutra: “Indeed a heuristic that is used for
deciding if an agent is hazardous is that a “good story”
can be told how the agent acts at each level of physical,
chemical and biological organization” [8]. Usually, “the
“story” is pieced together from many experiments [and
observations] over time. Under this heuristic, the more
steps on the story one can fill in, the more one believes
that the link between [shift work and cancer] .... is cau-
sal in nature” [8]. But in the context of this paper,
beyond contributing to telling a “good story” [8], “white-
box” epidemiology can be a means to answer key ques-
tions: ‘How good is the story?’ and, of paramount inter-
est, ‘how true is the story for public health?’ Clearly, it
is conceivable that scientific reasoning and data evince
an aesthetic thread. Indeed, we can think of scenarios
where numerous steps are filled in and make a “story”
[8] (seemingly) good to hear. But, equally clearly,
“white-box” epidemiology can put all the animal experi-
ments, mechanistic and other data in their proper com-
munity and medical perspective.
In theory, therefore, “white-box” epidemiology can
contribute to lending (or not) credibility to the story
about shift work and cancer. That story appears already
pretty good in IARC’s view. Yet, “white-box” epidemiol-
ogy can now be critical to tell us whether (or not) the
story is wrong or ‘likely true’ for humans. With regard
to identifying ‘true positives’,t h e‘likely’ carries a dual
qualification: First, insofar as observational research will
always disallow to verify that, what experiments would
predict, is valid. Recall Popper’ss w a ne x a m p l e :E v e n
observing one million white ones would not be proof
that all swans are white. However, observing just one
black swan will do to falsify the ‘all-swans-are-white
hypothesis’ [9]. Second, even the best story may still
turn out, despite all inferential scrutiny, as a ‘false posi-
tive’. After all, causal inference will remain a judgement,
not a certainty. No set of studies can produce 100 per
cent certainty that associations reflect a truly causal
effect. Quite differently, with regard to ‘true negatives’,
straightforward failure of “white-box” epidemiology to
observe what experimental animals, mechanistic and
other relevant data predict would actually render the
“story” [8] untrue.
In practice, let us suppose now that studies, designed
on the basis of biological or mechanistic insights, were
to show zero risks. On the one hand, reliable studies
with null results could imply that some shift work con-
ditions may be more favourable than others. This could
offer much-needed information for IARC under which
circumstances shift work may cause cancer and under
which not. On the other hand, flat indications of zero
cancer risks in biologically targeted epidemiological stu-
dies could be real-life observations signalling that -
despite being suggested by experimental data - the
links-in-question may be entirely irrelevant for humans.
Such demonstration of “Evidence suggesting lack of car-
cinogenicity” [[10]; p. 20] in epidemiological studies
should actually rule out an IARC Group 1 classification.
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refined by biological insights, were to convincingly
report statistical associations between shift work, CD
and cancers in man. We could derive several benefits
from such epidemiological associations. As one benefit,
they would tell us that a proposed “biochemical
mechanism may well be at work in the real world” [11].
As another benefit, and as a consequence for public
health, biological mechanism sd e r i v e df r o me x p e r i m e n -
tal animals, and from mechanistic and other relevant
data, could provide the biological rationale to interpret
statistical associations ultimately as reflecting a cause
and effect phenomenon. Shift work would - under the
surmised scenario - most likely be classified as a Group
1 carcinogen, i.e., it “is carcinogenic to humans“ [10]. To
fully appreciate the important role of biological plausi-
bility for the International Agency for Research on Can-
cer, please note also the following.
Suppose in this final scenario that IARC experts were
to judge evidence of carcinogenicity in humans to be
less than sufficient, for example, limited as in 2007. In
such case, however, IARC’s door is still open to put the
Group 1 label to an agent, or to an organizational work-
place feature like shift work, on the basis of biological
insights and plausibility alone. To do that, there must be
sufficient experimental animal evidence and strong
mechanistic evidence in exposed humans that the agent
acts via a relevant route that leads to cancer. This is
evinced when one reads the preamble to “IARC Mono-
graphs on the Evaluation of Carcinogenic Risks to
Humans” [[10]; p. 22].
IARC Group 1: The agent is carcinogenic to humans
“This category is used when there is sufficient evi-
dence of carcinogenicity in humans. Exceptionally, an
agent may be placed in this category when evidence
of carcinogenicity in humans is less than sufficient
but there is sufficient evidence of carcinogenicity in
experimental animals and strong evidence in
exposed humans that the agent acts through a rele-
vant mechanism of carcinogenicity”.
The imperative to have quality studies
In his 1994 commentary [7], from which I have quoted
already twice, David Savitz wrote: “With sufficient
understanding of the disease process based on disci-
plines other than epidemiology, there may be little need
for epidemiology to guide clinical practice or policy. Epi-
demiology of limited quality or quantity may suffice,
concentrating resources on the situations in which
refinements of epidemiologic information will be most
beneficial”.N o w ,i nm yv i e w ,D r .S a v i t z ’ premise “With
sufficient understanding of the disease process based on
disciplines other than epidemiology” is fulfilled in the
case of the hypothesized links between shift work, CD
and the development of internal cancers. But, impor-
tantly, with the sequitur “Epidemiology of limited quality
or quantity may suffice” I can not agree. To clarify my
point: A key requirement for any published study must
be the quality and validity of the study results and we
need, of course, appropriate replication ("quantity”)o f
epidemiological findings. Granted, we are looking at
abundant biomedical insights in disease processes from
disciplines beyond epidemiology, as is evinced by the
2007 IARC conclusion of “sufficient evidence in experi-
mental animals for the carcinogenicity of light during
the daily dark period (biological night)” [3]. This should,
however, not confer upon us the freedom to be more
flexible with regard to the quality and replication stan-
dards of observational studies in this field.
A key requirement, and key criterion, for publication
must be the quality of the studies. That biological plau-
sibility may be invoked to facilitate publication of epide-
miological research of inappropriate quality must be
avoided.
What may qualitative and quantitative reviews tell us
about the putative nexus of shift work, circadian
disruption or chronodisruption and cancer?
One way to systematically pave the road to quality stu-
dies is that we try to understand what studies regarding
shift work and cancer have already been conducted and
how. One means to exploit what is already there before
planning new observational studies is to conduct quali-
tative and quantitative reviews, including meta-analyses
as a “study of studies” [12].
When reviewing the scientific literature, it should cer-
tainly surprise that, so far, “circadian disruption” as the
critical link in the postulated chain of causation between
shift work and cancer has not been defined. Indeed, the
questions ‘what is circadian disruption?’ and ‘how can
we sensibly measure circadian disruption in observa-
tional studies?’ are still unanswered. In contrast, the
phenomenon of chronodisruption, which was operatio-
nalized in a qualitative and quantitative review [13]
summarized below and led independently of IARC to
very similar results, was first described in 2003 [14] and
systematically defined in 2009 [15].
Chronodisruption [CD], it was suggested [13-15], is a
relevant disturbance of the circadian organization of
physiology, endocrinology, metabolism and behaviour,
which links light, biological rhythms and the develop-
ment of cancers. More specifically, in 2008, the possible
links between CD and the development of cancers were
extended within a generalized theory [6]. “This theory
holds that CD can be understood as a critical loss of
time order, i.e. a disorder or chaos of an otherwise
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including the gene expression levels in individual cells”
[15]. And it was further specified that CD be “ab r e a k -
down of phasing internal biological systems appropri-
ately relative to the external, i.e. environmental changes,
which leads to chronobiological disorders” [15]. One
long-term consequence of this chronodisruption is pre-
sumed to be the development of cancer. Importantly,
“while melatonin as a key time messenger and time kee-
per can be a marker of CD, it is probably only partially
related to the differential cancer occurrence apparent in
individuals who chronically or frequently experience an
excess or deficit of chronodisruption” [6].
30 epidemiological studies were found eligible for
meta-analyses of breast or prostate cancer risks in flight
and shift personnel who were considered to have been
exposed to chronodisruption. Interestingly, statistical
analyses did not provide specific warning against com-
bining data in subsets of the 30 included studies. A 70%
and 40% increase in the risk of breast cancer in flight
personnel and shift personnel, respectively, and excess
relative risks of prostate cancer in flight personnel were
calculated. Moreover, the two studies of prostate cancer
in male shift workers available at the time were both
compatible with increased risks [16,17]. And yet, with
regard to the observed increased risks in shift workers
and flight personnel the following was concluded: “in
view of doubts about whether the differing assessments
of CD can really be regarded as valid reflections of the
same causative phenomenon and the lack of control of
covariates in the majority of studies, it is premature to
conclude that the risk observations reflect a real, rather
than spurious, association with CD. The challenge for
future epidemiological investigations of the biologically
plausible links between chronodisruption and human
cancers is to conduct studies which appreciate details of
transmeridian travelling, of shift work and of covariates
for the development of the diseases” [13].
On the basis of the qualitative and quantitative review,
a series of recommendations for future epidemiological
studies was developed. Apart from standard information
in cancer research such as the workers’ ages, medica-
tion, exercise et cetera, future epidemiologic studies
must include critical details of shift work: The length of
the shift, the speed of changes in schedules, and the
direction, i.e., forward or clockwise and backward or
counter-clockwise rotating shifts [18]...and so on.
As another consequence of the 2008 review, in order to
assess chronodisruption approriately, so-called chronodis-
ruptors have been defined [15]. This was done to identify
facets which epidemiologists might want to consider when
doing their studies in the shift work and cancer field. In
addition to much-needed details on the shift work expo-
sures [19], it is here that we should be as careful as
possible when planning, conducting, analysing and inter-
preting epidemiologic studies: “Chronodisruptors are exo-
genous and endogenous exposures or effectors which are
chronobiolocially active and can thus disrupt the timing
and order, i.e. temporal organization of physiologic func-
tions and hierarchies. In principle, whatever allows the
establishment of temporal organizational order in organ-
isms should also be capable of disrupting such order or
temporal programme when present or applied in excess or
deficit and, most importantly, at unusual and inappropri-
ate times, especially if combined with further agonistic or
antagonistic chronobiologial effectors” [15]. In view of the
Zeitgeber multiplicity to which shift workers are exposed
[20], any observational study should include information
on, and/or discussion of, the following intermediates or
covariates, and their possible interactions, along the postu-
lated chain(s) of cancer causation: Light, melatonin, sleep,
food [21-23], work and leisure activities, biological stress
and ambient noise [20].
A prime variable identified for future studies, not
included in the observational studies published until
2008 [13], and indeed until today, would be the chrono-
type of study individuals. Note, that so-called ‘owls’ are
likely to suffer considerably less from nightshift work
than the ‘lark-types’ in human populations. Ultimately,
therefore, the chronotype may explain why among
workers, who share the same shift work exposures,
some may develop cancer and others not or why some
develop it earlier and others later. In addition, it seems
reasonable to consider chronotype also in studies which
contrast groups with assumed major differences in their
average exposures to shift work. In such studies, indivi-
duals’ chronotype could be a covariate which might help
to explain within-group variations of cancer. Yet, there
is one more reason as to why adjusting for chronotype
characteristics could critically improve observational stu-
dies: Such information can be obtained and interpreted
more readily than information on clock gene variants or
polymorphisms [24] and other genetic characteristics in
sizeable populations. Intriguingly, from a mechanistic
point of view, the chronotype may actually mirror
genetic information which is otherwise difficult to
include and consider.
What epidemiological studies could be conducted in a
near(er) future: a sobering look ahead
The need to resolve biologically plausible cancer hazards
associated with shift work will lead to a host of observa-
tional studies into the issues involved. Each epidemiolo-
gical study will provide information in its own right. In
addition, such studies as a whole may bring us the sig-
nificant new data which can prompt a re-evaluation by
IARC of what exactly is the nature of links between
shift work, CD and internal cancers.
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probability we will witness - possibly erroneously -
‘positive association’ studies in the nearer future. First,
publication bias still facilitates publication of ‘positive
studies’ [25]. This is particularly true in a research field
such as shift work and cancer which does already attract
considerable public interest. Second, case-control studies
which obtain exposure information via questionnaires
rather than being based on (rather) unbiased industry-
records [26] can be conducted in a relatively fast fash-
ion. However, such studiesm a yb ep r o n et oc r i t i c a l
self-selection bias among the controls and to recall bias
among the cases. This problem of falsely producing
‘positive risk estimates’ was recently highlighted by Pirie
and colleagues. Their qualitative and quantitative review
showed that, in some studies of passive smoking and
breast cancer, women were more likely to report past
exposures because they knew that they had developed
breast cancer [27].
Conclusions
Overall, I can’t put my conclusions too strongly. Experi-
mental researchers from many disciplines are working at
every level to understand the nature of the temporal
organisation of biology - from sub-cellular biochemistry,
to whole cells, to organs, to organisms, including ani-
mals and humans - and its implications for the develop-
ment of cancer. And yet, it will be up to epidemiology
to provide, in line with Sir Richard Doll’s quote prefa-
cing this text, key observational evidence as to whether,
what appears biologically plausible today, has relevance
for public health. Necessary real-life studies will be a
challenge [28], but epidemiologic investigations of the
suspected links and causal interpretation of possibly
observed associations should benefit from ‘boxes’ which
are not black and empty [29] but rather white and full
with plausible disease mechanisms provided by experi-
mental scientists.
Importantly, though, we must be prepared for and
remain critical of qualitatively inferior studies in a
nearer future as they may invoke the suggestive biologi-
cal plausibility to support, and get published, invalid epi-
demiologic results.
In the meantime, I think that another reference to
Hill’s seminal paper [4] is warranted with regard to
possible prevention: “All scientific work is incomplete -
whether it be observational or experimental. All scienti-
fic work is liable to be upset or modified by advancing
knowledge. That does not confer upon us a freedom to
ignore the knowledge we already have or to postpone
the action that it appears to demand at a given time
(p 300)” [4]. In this vein, syntheses of our current
knowledge on countermeasures towards adverse effects
of shift work [30-32], are welcome. In addition, the
frequent evaluation ‘when to act and when to study’
should be modified in the complex fields of shift work
and health. More generally, we do need both, studies
and actions with regard to generating shift work condi-
tions with less or, preferably, no impact on cancer devel-
opments and other detrimental health outcomes. More
specifically, despite numerous shift work investigations
to-date, we need to study further how to act. In the lat-
ter respect, reliable studies with null results must be
published [33]: They may not only be important to the
overall assessment as to whether shift work conditions
lead to increased cancer risks in some individuals but
also that some shift work conditions may be more
favourable than others. Provided that associations
between CD and cancer were eventually to be inter-
preted as causal, real life observational studies would be
a basis for assessing what shift work exposures, and
what level of CD, may be tolerable and what is
unacceptable.
To foster “white-box” epidemiological studies and to
ultimately reach sound public health decisions regarding
shift work and cancer, here are seven recommendations:
How biological plausibility should be used to design, to
report and to interpret epidemiological studies
1. Biological insights and plausibility should be used
to design and refine epidemiologic investigations.
The challenge for studies of biologically plausible
links between shift work, CD and human cancers is
to appreciate details of shift work and of covariates
for the development of the diseases.
2. We shall need observational studies of different
shift-regimens at different workplaces. Moreover, we
will need such studies for women and for men. Such
studies should be - whenever possible - adjusted for
chronotype information. This can be obtained and
interpreted more readily than information on clock
gene variants [24] and other genetic characteristics
in sizeable populations. In addition, such chronotype
information may encompass a lot of other informa-
tion relevant to study individuals’ chronobiology in a
feasible fashion.
3. In view of the wealth of biological information
and seemingly overwhelming evidence in support of
mechanistic causality, the primary objective of the
studies should be to accurately collect and present
methods and data. Rather than over-interpretation of
observed associations as reflecting causal relation-
ships, this very focus on epidemiological facts could
allow “w r i t e r sm o r et i m ea n dt h er e p o r tm o r es p a c e
to describe the methods, analyses and data” [34].
Authors should let peers reading detailed descriptive
accounts of possibly important epidemiological
research develop explanations for the findings.
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of the studies. Biological plausibility should not be
invoked to facilitate publication of epidemiological
research of inappropriate quality.
5. The outcome of ‘biological plausibility’ should be
considered open. We must not be hypnotized by the
tantalizing status quo of experimental and mechanis-
tic evidence. Indeed, we should be prepared to
decide ourselves, or be guided by more experts, on
the evidence available in coming years. For instance,
new animal data then may make strongly incriminat-
ing mechanistic evidence available today less or no
longer persuasive. Thus, how the available experi-
mental evidence has to be judged then, whether it
provides - still, less or even more so - a biological
rationale to guide the design of observational studies
and to interpret observations as reflecting (or not) a
cause-effect-phenomenon, is open today.
6. The outcome of “white-box” epidemiological stu-
dies should be considered open. Making use of
insights into biological candidate mechanisms may
lead to (very) different studies with (very) different
results, both with regard to the direction and the
magnitude of putative cancer risks. In the future,
biologically targeted studies may show (much)
higher, lower or no risks at all.
7. Ultimately, biological insights and plausibility
should be used to weigh the overall scientific evi-
dence to rule in or rule out causality. Insights into
plausible mechanisms may then provide a biological
rationale to judge that associations observed between
shift work and cancer do (or do not) reflect a cause
and effect phenomenon.
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